G. D’Haens

[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)].

S. Travis, M. Sans, J. Lindsay, 2015, Revista de gastroenterologia de Mexico.

Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management

S. Vermeire, S. Travis, M. Sans, 2012 .

Anti-MAdCAM-1 Antibody (PF-00547659) for Active Refractory Crohn's Disease: Results of the OPERA study

W. Reinisch, X. Hébuterne, J. Claus, 2015 .

EDITOR’S QUIZ: GI SNAPSHOT

P. Rutgeerts, S. Vermeire, F. Baert, 2007, Gut.

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling

S. Vermeire, C. Ponsioen, A. B. van 't Wout, 2019, Gut.

Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management

S. Travis, M. Sans, J. Lindsay, 2012 .

Low prevalence of Blastocystis sp. in active ulcerative colitis patients

E. van Nood, C. Ponsioen, G. D'Haens, 2015, European Journal of Clinical Microbiology & Infectious Diseases.